Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

BUY
$118.38 - $210.04 $1.54 Million - $2.73 Million
13,000 New
13,000 $2.34 Million
Q2 2022

Aug 10, 2022

SELL
$117.13 - $176.59 $1.17 Million - $1.77 Million
-10,000 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$126.46 - $235.05 $1.26 Million - $2.35 Million
10,000 New
10,000 $1.72 Million
Q2 2021

Aug 10, 2021

SELL
$129.91 - $234.98 $1.95 Million - $3.52 Million
-15,000 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$109.18 - $185.98 $1.64 Million - $2.79 Million
15,000 New
15,000 $1.96 Million
Q1 2019

May 08, 2019

SELL
$14.45 - $23.7 $361,250 - $592,500
-25,000 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$13.52 - $18.8 $338,000 - $470,000
25,000 New
25,000 $382,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Sivik Global Healthcare LLC Portfolio

Follow Sivik Global Healthcare LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivik Global Healthcare LLC with notifications on news.